• Explore /
  • Poster
  • / Prognostic value of <em>EZH2</em> expression for immunotherapy-based schemes in advanced soft-tissue sarcoma: A translational research from Spanish Group of Research on Sarcoma (GEIS).

Prognostic value of EZH2 expression for immunotherapy-based schemes in advanced soft-tissue sarcoma: A translational research from Spanish Group of Research on Sarcoma (GEIS).

Abstract Poster

Authors

null

David Silva Moura

Group of Advanced Therapies and Biomarkers in Sarcomas, Health Research Institute-Fundación Jiménez Díaz University Hospital, Madrid, Spain

David Silva Moura , Jorge Zamora , Nadia Hindi , Maria Lopez-Alvarez , Serena Lacerenza , Giovanni Grignani , Javier Martinez-Trufero , Andres Redondo , Claudia Maria Valverde Morales , Silvia Stacchiotti , Antonio Lopez-Pousa , Antonio Gutierrez , Jose A. Lopez-Martin , Javier Martin Broto

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2022 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Sarcoma

Track

Sarcoma

Sub Track

Molecular Targets/Biomarkers/Tumor Biology

Citation

J Clin Oncol 40, 2022 (suppl 16; abstr 11549)

DOI

10.1200/JCO.2022.40.16_suppl.11549

Abstract #

11549

Poster Bd #

453

Abstract Disclosures

Similar Posters

First Author: Ahmad A. Tarhini

First Author: Audreylie Lemelin

First Author: Chris Labaki

First Author: Ulka N. Vaishampayan